Insider Shareholders with Direct Ownership of Immunome Inc. (IMNM)
This section provides a comprehensive overview of the insiders with direct ownership of Immunome Inc. (IMNM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Immunome Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michael Rapp
Director |
910,192 | 0 | 1,071,172 $14.5 Million | 3 |
Oct 02, 2023
Added 19.16%
|
|
I Wistar Morris Iii
> 10% Shareholder |
882,475 | 0 | 882,475 $12 Million | 1 |
Oct 06, 2020
Added 50.0%
|
|
Clay B Siegall
President and CEO |
369,204 | 0 | 519,636 $7.06 Million | 5 |
Nov 22, 2024
Added 6.13%
|
| 22,250 | 0 | 406,147 $5.52 Million | 2 |
Jan 15, 2023
Added 2.11%
|
|
|
John L Lamattina
Director |
66,953 | 0 | 66,953 $909,221 | 3 |
Jan 15, 2023
Added 18.43%
|
|
Franklyn G Prendergast
Director |
60,840 | 0 | 60,840 $826,207 | 1 |
Oct 02, 2023
Added 50.0%
|
|
Michael Widlitz
Director |
51,315 | 0 | 51,315 $696,857 | 1 |
Oct 06, 2020
Added 50.0%
|
|
Max Rosett
Chief Financial Officer |
42,000 | 14,380 | 47,476 $644,724 | 2 |
Sep 19, 2024
Reduced 23.25%
|
|
Bruce Turner
Chief Strategy Officer |
42,300 | 0 | 42,300 $574,434 | 1 |
Oct 02, 2023
Added 50.0%
|
|
Michael Lefenfeld
Director |
40,747 | 0 | 40,747 $553,344 | 5 |
Jan 15, 2023
Added 25.4%
|
|
Philip Tsai
Chief Technology Officer |
21,000 | 0 | 21,000 $285,180 | 1 |
Nov 21, 2024
Added 50.0%
|
| 9,000 | 0 | 16,615 $225,631 | 2 |
Aug 16, 2024
Added 29.64%
|
|
|
Robert Lechleider
Chief Medical Officer |
15,805 | 0 | 15,805 $214,631 | 1 |
Nov 21, 2024
Added 50.0%
|
|
Jack Higgins
Chief Scientific Officer |
19,524 | 5,995 | 13,529 $183,723 | 3 |
Aug 19, 2024
Reduced 15.44%
|
|
Purnanand D Sarma
President and CEO |
10,500 | 0 | 10,500 $142,590 | 1 |
May 25, 2021
Added 50.0%
|
|
Richard A Baron
Director |
2,343 | 0 | 2,343 $31,817 | 1 |
Aug 18, 2021
Added 50.0%
|